Alpharix-Tetra

Alpharix-Tetra is a vaccine designed to protect against influenza virus strains, including B/Phuket/3073/2013-like virus and B/Austria/1359417/2020. This intramuscular vaccine is manufactured by Glaxosmithkline Biologicals S.A. and is suitable for EU markets.

Alpharix-Tetra is used for the prevention of influenza caused by specific virus strains. It is typically administered to individuals seeking protection against seasonal flu. This vaccine is part of a broader strategy to reduce the incidence of influenza and its associated complications.

Common effects of Alpharix-Tetra may include mild soreness or redness at the injection site. Some individuals might experience temporary discomfort or low-grade fever following vaccination. These effects are generally mild and short-lived.

Alpharix-Tetra should be administered by healthcare professionals. Individuals with a history of severe allergic reactions to previous influenza vaccines or any of its components should consult their healthcare provider before use. Always follow the recommended storage and handling guidelines.

Alpharix-Tetra may interact with other medications or vaccines. It is advisable to inform your healthcare provider about any other vaccines or medications you are currently taking. Specific interactions with over-the-counter drugs or supplements should also be discussed with a healthcare professional.